Dry powder inhalers show benefits for asthma control, environment
Feb 08, 2022
Switching to dry powder inhaler more than halves carbon footprint of asthma treatment without asthma worsening
NIH: Inhaled moisturizing drug boosts lung function in severe COPD
By
Alicia Lasek
Feb 02, 2021
The biologic drug hyaluronan improved lung function in patients hospitalized for severe exacerbation of chronic obstructive pulmonary disease, a new study finds.
Continue to take allergy and asthma meds during COVID-19 outbreak: experts
By
Alicia Lasek
Apr 05, 2020
Getting symptoms under control early in the allergy season may be the safest action at this time, say leading immunologists.
Inhaler receives Arthritis Foundation ‘Ease of Use’ commendation
Jan 17, 2018
Boehringer Ingelheim’s Respimat Inhaler, designed for those with arthritis, has received the Arthritis Foundation Ease of Use Commendation.
FDA approves Anoro Ellipta
Dec 20, 2013
The U.S. Food and Drug Administration have approved GlaxoSmithKline’s Anoro™ Ellipta™, the company announced. The product is used to treat chronic obstructive pulmonary disease.